Rapamycin Holdings Launches First Human Clinical Trial of Its eRapa Compound Targeting Early Stage Prostate Cancer

  • Michael A Liss

Press/Media: Press / Media

PeriodSep 21 2018

Media coverage

1

Media coverage

  • TitleRapamycin Holdings Launches First Human Clinical Trial of Its eRapa Compound Targeting Early Stage Prostate Cancer
    Media name/outletHealth & Beauty Close-Up(Close-up Media)
    CountryUnited States
    Date9/21/18
    PersonsMichael A Liss